Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Research Report 2024

Report ID: 1978131 | Published Date: Jan 2025 | No. of Page: 64 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 GYR-12
        1.2.3 DS-2969
        1.2.4 VXC-100
        1.2.5 VT-12008911
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Bacterial Infections
        1.3.3 Clostridium Diffclie Infections
        1.3.4 Klebsiella Pneumoniae Infections
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Perspective (2017-2028)
    2.2 DNA Gyrase Subunit B (EC 5.99.1.3) Growth Trends by Region
        2.2.1 DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 DNA Gyrase Subunit B (EC 5.99.1.3) Historic Market Size by Region (2017-2022)
        2.2.3 DNA Gyrase Subunit B (EC 5.99.1.3) Forecasted Market Size by Region (2023-2028)
    2.3 DNA Gyrase Subunit B (EC 5.99.1.3) Market Dynamics
        2.3.1 DNA Gyrase Subunit B (EC 5.99.1.3) Industry Trends
        2.3.2 DNA Gyrase Subunit B (EC 5.99.1.3) Market Drivers
        2.3.3 DNA Gyrase Subunit B (EC 5.99.1.3) Market Challenges
        2.3.4 DNA Gyrase Subunit B (EC 5.99.1.3) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top DNA Gyrase Subunit B (EC 5.99.1.3) Players by Revenue
        3.1.1 Global Top DNA Gyrase Subunit B (EC 5.99.1.3) Players by Revenue (2017-2022)
        3.1.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Players (2017-2022)
    3.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by DNA Gyrase Subunit B (EC 5.99.1.3) Revenue
    3.4 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Concentration Ratio
        3.4.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by DNA Gyrase Subunit B (EC 5.99.1.3) Revenue in 2021
    3.5 DNA Gyrase Subunit B (EC 5.99.1.3) Key Players Head office and Area Served
    3.6 Key Players DNA Gyrase Subunit B (EC 5.99.1.3) Product Solution and Service
    3.7 Date of Enter into DNA Gyrase Subunit B (EC 5.99.1.3) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 DNA Gyrase Subunit B (EC 5.99.1.3) Breakdown Data by Type
    4.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Historic Market Size by Type (2017-2022)
    4.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Forecasted Market Size by Type (2023-2028)
5 DNA Gyrase Subunit B (EC 5.99.1.3) Breakdown Data by Application
    5.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Historic Market Size by Application (2017-2022)
    5.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (2017-2028)
    6.2 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2017-2022)
    6.3 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (2017-2028)
    7.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2017-2022)
    7.3 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (2017-2028)
    8.2 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2017-2022)
    8.3 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (2017-2028)
    9.2 Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2017-2022)
    9.3 Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (2017-2028)
    10.2 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2017-2022)
    10.3 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abgentis Limited
        11.1.1 Abgentis Limited Company Detail
        11.1.2 Abgentis Limited Business Overview
        11.1.3 Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Introduction
        11.1.4 Abgentis Limited Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2017-2022)
        11.1.5 Abgentis Limited Recent Development
    11.2 AstraZeneca Plc
        11.2.1 AstraZeneca Plc Company Detail
        11.2.2 AstraZeneca Plc Business Overview
        11.2.3 AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Introduction
        11.2.4 AstraZeneca Plc Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2017-2022)
        11.2.5 AstraZeneca Plc Recent Development
    11.3 Daiichi Sankyo Company Ltd
        11.3.1 Daiichi Sankyo Company Ltd Company Detail
        11.3.2 Daiichi Sankyo Company Ltd Business Overview
        11.3.3 Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Introduction
        11.3.4 Daiichi Sankyo Company Ltd Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2017-2022)
        11.3.5 Daiichi Sankyo Company Ltd Recent Development
    11.4 Merck & Co., Inc.
        11.4.1 Merck & Co., Inc. Company Detail
        11.4.2 Merck & Co., Inc. Business Overview
        11.4.3 Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Introduction
        11.4.4 Merck & Co., Inc. Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2017-2022)
        11.4.5 Merck & Co., Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of GYR-12
    Table 3. Key Players of DS-2969
    Table 4. Key Players of VXC-100
    Table 5. Key Players of VT-12008911
    Table 6. Key Players of Others
    Table 7. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Region (2017-2022)
    Table 11. Global DNA Gyrase Subunit B (EC 5.99.1.3) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Region (2023-2028)
    Table 13. DNA Gyrase Subunit B (EC 5.99.1.3) Market Trends
    Table 14. DNA Gyrase Subunit B (EC 5.99.1.3) Market Drivers
    Table 15. DNA Gyrase Subunit B (EC 5.99.1.3) Market Challenges
    Table 16. DNA Gyrase Subunit B (EC 5.99.1.3) Market Restraints
    Table 17. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Players (2017-2022)
    Table 19. Global Top DNA Gyrase Subunit B (EC 5.99.1.3) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) as of 2021)
    Table 20. Ranking of Global Top DNA Gyrase Subunit B (EC 5.99.1.3) Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players DNA Gyrase Subunit B (EC 5.99.1.3) Product Solution and Service
    Table 24. Date of Enter into DNA Gyrase Subunit B (EC 5.99.1.3) Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Type (2017-2022)
    Table 28. Global DNA Gyrase Subunit B (EC 5.99.1.3) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Type (2023-2028)
    Table 30. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Application (2017-2022)
    Table 32. Global DNA Gyrase Subunit B (EC 5.99.1.3) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Application (2023-2028)
    Table 34. North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Abgentis Limited Company Detail
    Table 45. Abgentis Limited Business Overview
    Table 46. Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Product
    Table 47. Abgentis Limited Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2017-2022) & (US$ Million)
    Table 48. Abgentis Limited Recent Development
    Table 49. AstraZeneca Plc Company Detail
    Table 50. AstraZeneca Plc Business Overview
    Table 51. AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Product
    Table 52. AstraZeneca Plc Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2017-2022) & (US$ Million)
    Table 53. AstraZeneca Plc Recent Development
    Table 54. Daiichi Sankyo Company Ltd Company Detail
    Table 55. Daiichi Sankyo Company Ltd Business Overview
    Table 56. Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Product
    Table 57. Daiichi Sankyo Company Ltd Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2017-2022) & (US$ Million)
    Table 58. Daiichi Sankyo Company Ltd Recent Development
    Table 59. Merck & Co., Inc. Company Detail
    Table 60. Merck & Co., Inc. Business Overview
    Table 61. Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Product
    Table 62. Merck & Co., Inc. Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2017-2022) & (US$ Million)
    Table 63. Merck & Co., Inc. Recent Development
    Table 64. Research Programs/Design for This Report
    Table 65. Key Data Information from Secondary Sources
    Table 66. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Type: 2021 VS 2028
    Figure 2. GYR-12 Features
    Figure 3. DS-2969 Features
    Figure 4. VXC-100 Features
    Figure 5. VT-12008911 Features
    Figure 6. Others Features
    Figure 7. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Application in 2021 & 2028
    Figure 8. Bacterial Infections Case Studies
    Figure 9. Clostridium Diffclie Infections Case Studies
    Figure 10. Klebsiella Pneumoniae Infections Case Studies
    Figure 11. Others Case Studies
    Figure 12. DNA Gyrase Subunit B (EC 5.99.1.3) Report Years Considered
    Figure 13. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Region: 2021 VS 2028
    Figure 16. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Players in 2021
    Figure 17. Global Top DNA Gyrase Subunit B (EC 5.99.1.3) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by DNA Gyrase Subunit B (EC 5.99.1.3) Revenue in 2021
    Figure 19. North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Country (2017-2028)
    Figure 21. United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Country (2017-2028)
    Figure 25. Germany DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Region (2017-2028)
    Figure 33. China DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Country (2017-2028)
    Figure 41. Mexico DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Country (2017-2028)
    Figure 45. Turkey DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Abgentis Limited Revenue Growth Rate in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2017-2022)
    Figure 48. AstraZeneca Plc Revenue Growth Rate in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2017-2022)
    Figure 49. Daiichi Sankyo Company Ltd Revenue Growth Rate in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2017-2022)
    Figure 50. Merck & Co., Inc. Revenue Growth Rate in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2017-2022)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abgentis Limited
AstraZeneca Plc
Daiichi Sankyo Company Ltd
Merck & Co., Inc.
Frequently Asked Questions
DNA Gyrase Subunit B (EC 5.99.1.3) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
DNA Gyrase Subunit B (EC 5.99.1.3) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
DNA Gyrase Subunit B (EC 5.99.1.3) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports